Drugs / HU-045
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05298449 | Mar → Nov 2022 | — | Huons Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HU-045 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05298449 ↗ |
| Route | Intramuscular | “injected into muscles” NCT05298449 ↗ |